SETD7 and cancer: Under hypoxic conditions, SET7/9 has been shown to mediate the survival of various cancer cells against hypoxic stress by promoting HIF-1α protein stability and enhancing HIF-1-mediated gene transcription in osteosarcoma, hepatoma, and renal cell carcinoma [197].